Mechanism of heterochromatin assembly
异染色质组装机制
基本信息
- 批准号:8694896
- 负责人:
- 金额:$ 32.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-07-01 至 2018-02-28
- 项目状态:已结题
- 来源:
- 关键词:AcetylationAffectAnimal ModelBerylliumBindingBiochemicalBypassCancer BiologyCancer PatientCellsCentromereChromatinChromatin StructureChromosome SegregationChromosome StructuresComplexCoupledDNADNA biosynthesisDNA-Directed RNA PolymeraseDataDefectDevelopmentDiseaseElementsEnsureEnzymesEpigenetic ProcessFeedbackFission YeastGene ExpressionGene Expression ProfileGene SilencingGenerationsGeneticGenetic MaterialsGenetic RecombinationGenetic TranscriptionGenomeGenomicsGoalsHeterochromatinHistonesHumanInvestigationLocationMaintenanceMalignant NeoplasmsMating TypesMediatingMeiosisMethylationMethyltransferaseMitosisModelingModificationMolecularMutationOrganismPathway interactionsPhenocopyPhosphorylationPlayPositioning AttributeProcessProteinsRNA InterferenceRNA Interference PathwayRecruitment ActivityRegulationRepetitive SequenceRoleSiteSmall Interfering RNAStructureSuppressor MutationsTertiary Protein StructureTestingTranscriptTumor-Suppressor Gene Inactivationbasedevelopmental diseasehistone acetyltransferasehistone modificationinsightmutantpublic health relevanceresearch studysegregationtelomeretumor progression
项目摘要
DESCRIPTION (provided by applicant):
Project Summary Covalent modifications of histones, such as acetylation, methylation, phosphorylation, and ubiquitylation, are essential regulators of chromatin structure and function. Defects in the regulation of these modifications have causal roles in numerous developmental disorders and diseases. However, the mechanisms that target histone-modifying enzymes to specific genomic locations and regulate their enzymatic activities are not well understood. Our long-term goal is to understand how diverse histone modification activities are coordinated to initiate and maintain different epigenetic states. Heterochromatin preferentially assembles at repetitive DNA elements. It is critical for setting up gene expression patterns during development and maintaining genome integrity by rendering repetitive structures recombinationally inert. It is also crucial for functional organization of vital chromosomal structures such as centromeres and telomeres, ensuring the accurate segregation of genetic material during mitosis and meiosis. Heterochromatin formation requires the concerted actions of diverse histone modifying enzymes as well as the RNA interference (RNAi) machinery. Paradoxically, transcription of the underlying repetitive DNA elements is also required for proper heterochromatin assembly, although heterochromatin generally represses transcription. These transcripts not only serve as substrates for RNAi to produce small interfering RNAs (siRNAs), but also as a platform for the recruitment of histone-modifying enzymes through siRNA-containing effector complexes. Histone modifications in turn stabilize the binding of the RNAi machinery to heterochromatin. As a result, processing of transcripts by RNAi and recruitment of histone modifying activities are tightly coupled, making it difficult to identify the initial signas that target repetitive regions for heterochromatin assembly. We have recently discovered that loss of a number of factors allows cells to bypass the requirement of the RNAi machinery for heterochromatin assembly. Our studies of the one class of these factors, the Mst2 histone acetyltransferase complex, revealed that reducing RNA polymerase recruitment to heterochromatin during DNA replication is essential for the inheritance of the heterochromatic state through generations. The goal of this proposal is to further understand how loss of diverse activities could bypass the RNAi requirement for heterochromatin assembly. These analyses will provide molecular mechanisms of how heterochromatin-promoting activities are regulated to control the initiation, spreading, and maintenance of heterochromatin domains.
描述(由申请人提供):
项目摘要的组蛋白的共价修饰,例如乙酰化,甲基化,磷酸化和泛素化,是染色质结构和功能的必不可少的调节剂。这些修饰的调节缺陷在许多发育障碍和疾病中具有因果关系。但是,尚不清楚将组蛋白改性酶定为特定基因组位置并调节其酶促活性的机制。我们的长期目标是了解如何协调多样化的组蛋白修饰活动以启动和维持不同的表观遗传状态。异染色质优先组装在重复的DNA元件上。这对于通过使重复结构重组惰性在发育过程中建立基因表达模式和维持基因组完整性至关重要。它对于诸如丝粒和端粒等重要染色体结构的功能组织也至关重要,从而确保有丝分裂和减数分裂过程中遗传物质的准确分离。异染色质形成需要各种组蛋白修饰酶以及RNA干扰(RNAI)机械的一致作用。矛盾的是,适当的异染色质组装也需要基础重复的DNA元素的转录,尽管异染色质通常会抑制转录。这些转录本不仅是RNAi产生小干扰RNA(siRNA)的底物,而且还可以作为通过含siRNA效应子复合物复合物募集组蛋白修饰酶募集的平台。组蛋白的修饰又稳定了RNAi机械与异染色质的结合。结果,通过RNAi处理转录本和募集组蛋白修饰活性的募集是紧密耦合的,因此很难识别出靶向异染色质组装的重复区域的初始签名。我们最近发现,多种因素的损失使细胞绕过RNAi机械对异染色质组装的需求。我们对这些因素的一类MST2组蛋白乙酰转移酶复合物的研究表明,在DNA复制过程中,将RNA聚合酶募集减少到异染色质对异染色质的过程对于世代相传的杂色状态至关重要。该提案的目的是进一步了解各种活动的损失如何绕开RNAi对异染色质组装的需求。这些分析将提供分子机制,说明如何调节异染色质活性以控制异染色质结构域的起始,扩散和维持。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Songtao Jia其他文献
Songtao Jia的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Songtao Jia', 18)}}的其他基金
Mechanism of heterochromatin assembly and oncogenic histone mutations
异染色质组装和致癌组蛋白突变的机制
- 批准号:
9757798 - 财政年份:2018
- 资助金额:
$ 32.33万 - 项目类别:
Mechanism of heterochromatin assembly and oncogenic histone mutations
异染色质组装和致癌组蛋白突变的机制
- 批准号:
10591133 - 财政年份:2018
- 资助金额:
$ 32.33万 - 项目类别:
Mechanism of heterochromatin assembly and oncogenic histone mutations
异染色质组装和致癌组蛋白突变的机制
- 批准号:
10457495 - 财政年份:2018
- 资助金额:
$ 32.33万 - 项目类别:
Mechanism of heterochromatin assembly and oncogenic histone mutations
异染色质组装和致癌组蛋白突变的机制
- 批准号:
9975193 - 财政年份:2018
- 资助金额:
$ 32.33万 - 项目类别:
Mechanism of Heterochromatin Assembly and epigenetic inheritance
异染色质组装和表观遗传机制
- 批准号:
10619175 - 财政年份:2018
- 资助金额:
$ 32.33万 - 项目类别:
Mechanism of heterochromatin assembly and oncogenic histone mutations
异染色质组装和致癌组蛋白突变的机制
- 批准号:
10219813 - 财政年份:2018
- 资助金额:
$ 32.33万 - 项目类别:
HISTONE METHYLATION AND EPIGENETIC CONTROL OF THE GENOME
组蛋白甲基化和基因组的表观遗传控制
- 批准号:
8171330 - 财政年份:2010
- 资助金额:
$ 32.33万 - 项目类别:
HISTONE METHYLATION AND EPIGENETIC CONTROL OF THE GENOME
组蛋白甲基化和基因组的表观遗传控制
- 批准号:
7957716 - 财政年份:2009
- 资助金额:
$ 32.33万 - 项目类别:
Epigenetic regulation by PWWP domain proteins
PWWP 结构域蛋白的表观遗传调控
- 批准号:
7895337 - 财政年份:2009
- 资助金额:
$ 32.33万 - 项目类别:
Epigenetic regulation by PWWP domain proteins
PWWP 结构域蛋白的表观遗传调控
- 批准号:
8063643 - 财政年份:2008
- 资助金额:
$ 32.33万 - 项目类别:
相似国自然基金
肾—骨应答调控骨骼VDR/RXR对糖尿病肾病动物模型FGF23分泌的影响及中药的干预作用
- 批准号:82074395
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:面上项目
基于细胞自噬调控的苦参碱对多囊肾小鼠动物模型肾囊肿形成的影响和机制研究
- 批准号:
- 批准年份:2019
- 资助金额:33 万元
- 项目类别:地区科学基金项目
NRSF表达水平对抑郁模型小鼠行为的影响及其分子机制研究
- 批准号:81801333
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
靶向诱导merlin/p53协同性亚细胞穿梭对听神经瘤在体生长的影响
- 批准号:81800898
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
伪狂犬病病毒激活三叉神经节细胞对其NF-кB和PI3K/Akt信号转导通路影响的分子机制研究
- 批准号:31860716
- 批准年份:2018
- 资助金额:39.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Oxidative Stress and Mitochondrial Dysfunction in Chemogenetic Heart Failure
化学遗传性心力衰竭中的氧化应激和线粒体功能障碍
- 批准号:
10643012 - 财政年份:2023
- 资助金额:
$ 32.33万 - 项目类别:
Sex differences in stress inoculation of addiction-like phenotypes
成瘾样表型应激接种的性别差异
- 批准号:
10757580 - 财政年份:2023
- 资助金额:
$ 32.33万 - 项目类别:
Role of Mettl3-dependent RNA m6A dysregulation in Alzheimer's disease
Mettl3 依赖性 RNA m6A 失调在阿尔茨海默病中的作用
- 批准号:
10739065 - 财政年份:2023
- 资助金额:
$ 32.33万 - 项目类别:
Chromatin and metabolic regulation of plasticity in a predatory nematode
捕食性线虫可塑性的染色质和代谢调节
- 批准号:
10715689 - 财政年份:2023
- 资助金额:
$ 32.33万 - 项目类别:
Characterize neuronal and glial cell-specific vulnerability to proteinopathies in Alzheimer's disease using multimodal single-nuclei genomic and epigenomic approaches
使用多模式单核基因组和表观基因组方法表征阿尔茨海默病中神经元和神经胶质细胞对蛋白质病的特异性脆弱性
- 批准号:
10666954 - 财政年份:2023
- 资助金额:
$ 32.33万 - 项目类别: